Variant report

Variant	esv3429780
Chromosome Location	chr9:136607447-136628052
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:136610599-136611196	HepG2	liver:	n/a	n/a
2	ARID3A	chr9:136608175-136608482	HepG2	liver:	n/a	n/a
3	ATF2	chr9:136608026-136608541	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF3	chr9:136608115-136608342	K562	blood:	n/a	n/a
5	BCL3	chr9:136619970-136620250	GM12878	blood:	n/a	n/a
6	BHLHE40	chr9:136608177-136608525	K562	blood:	n/a	n/a
7	BHLHE40	chr9:136608124-136608444	GM12878	blood:	n/a	n/a
8	BHLHE40	chr9:136608081-136608427	HepG2	liver:	n/a	n/a
9	BHLHE40	chr9:136608128-136608200	A549	lung:	n/a	n/a
10	BRCA1	chr9:136608094-136608314	HepG2	liver:	n/a	n/a
11	CBX3	chr9:136608129-136608507	K562	blood:	n/a	n/a
12	CEBPB	chr9:136608104-136608450	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr9:136610710-136611063	HepG2	liver:	n/a	n/a
14	CEBPB	chr9:136610742-136610992	HepG2	liver:	n/a	n/a
15	CEBPB	chr9:136610701-136611087	HepG2	liver:	n/a	n/a
16	CEBPB	chr9:136610747-136611024	HepG2	liver:	n/a	n/a
17	CEBPD	chr9:136610728-136611024	HepG2	liver:	n/a	n/a
18	CEBPZ	chr9:136611934-136612115	HepG2	liver:	n/a	n/a
19	CHD2	chr9:136610741-136610945	HepG2	liver:	n/a	n/a
20	CHD2	chr9:136608135-136608400	Hela-S3	cervix:	n/a	n/a
21	CREB1	chr9:136608122-136608354	A549	lung:	n/a	n/a
22	CREB1	chr9:136608072-136608444	A549	lung:	n/a	n/a
23	CTCF	chr9:136608180-136608330	HAc	cerebellar:	n/a	chr9:136608256-136608265
24	CTCF	chr9:136608200-136608350	Caco-2	colon:	n/a	chr9:136608256-136608265
25	CTCF	chr9:136608200-136608350	HBMEC	blood vessel:	n/a	chr9:136608256-136608265
26	CTCF	chr9:136608240-136608390	NHEK	skin:	n/a	chr9:136608256-136608265
27	CTCF	chr9:136608060-136608330	A549	lung:	n/a	chr9:136608256-136608265
28	CTCF	chr9:136608200-136608350	HAc	cerebellar:	n/a	chr9:136608256-136608265
29	CTCF	chr9:136608180-136608330	GM12873	blood:	n/a	chr9:136608256-136608265
30	CTCF	chr9:136608200-136608350	AG04450	lung:	n/a	chr9:136608256-136608265
31	CTCF	chr9:136607500-136607650	GM12873	blood:	n/a	n/a
32	CTCF	chr9:136608200-136608350	BJ	skin:	n/a	chr9:136608256-136608265
33	CTCF	chr9:136608180-136608330	GM12870	blood:	n/a	chr9:136608256-136608265
34	CTCF	chr9:136607925-136607996	GM10248	blood:	n/a	n/a
35	CTCF	chr9:136608200-136608350	HUVEC	blood vessel:	n/a	chr9:136608256-136608265
36	CTCF	chr9:136608240-136608390	HBMEC	blood vessel:	n/a	chr9:136608256-136608265
37	CTCF	chr9:136608132-136608442	LNCaP	prostate:	n/a	chr9:136608256-136608265
38	CTCF	chr9:136608200-136608350	GM12870	blood:	n/a	chr9:136608256-136608265
39	CTCF	chr9:136607880-136608030	GM12866	blood:	n/a	n/a
40	CTCF	chr9:136608220-136608370	HRE	kidney:	n/a	chr9:136608256-136608265
41	CTCF	chr9:136608220-136608370	RPTEC	kidney:	n/a	chr9:136608256-136608265
42	CTCF	chr9:136608160-136608310	GM12872	blood:	n/a	chr9:136608256-136608265
43	CTCF	chr9:136608200-136608350	GM12868	blood:	n/a	chr9:136608256-136608265
44	CTCF	chr9:136607852-136608903	A549	lung:	n/a	chr9:136608256-136608265
45	CTCF	chr9:136608115-136608444	GM10266	blood:	n/a	chr9:136608256-136608265
46	CTCF	chr9:136608200-136608350	GM12865	blood:	n/a	chr9:136608256-136608265
47	CTCF	chr9:136607892-136608006	GM12891	blood:	n/a	n/a
48	CTCF	chr9:136608139-136608417	GM20000	blood:	n/a	chr9:136608256-136608265
49	CTCF	chr9:136608220-136608370	GM12801	blood:	n/a	chr9:136608256-136608265
50	CTCF	chr9:136608043-136608568	K562	blood:	n/a	chr9:136608256-136608265

No.	Distal block	Cell Line	Cell type
1	chr9:136623159..136624701-chr9:136627803..136630667,2	K562	blood:
2	chr9:136606898..136609884-chr9:136619797..136622653,2	MCF-7	breast:
3	chr9:136617189..136619895-chr9:136623419..136625619,3	MCF-7	breast:
4	chr9:136622818..136624758-chr9:136635199..136637676,2	MCF-7	breast:
5	chr9:136608275..136608832-chr9:136966155..136966872,2	K562	blood:
6	chr9:136623857..136625916-chr9:136737465..136739989,2	MCF-7	breast:
7	chr9:136608029..136608531-chr9:136858192..136859169,2	MCF-7	breast:
8	chr9:136617189..136619895-chr9:136623419..136625619,3	MCF-7	breast:
9	chr9:136625089..136627399-chr9:136858004..136860328,2	MCF-7	breast:
10	chr9:136622711..136625053-chr9:136627344..136629303,3	MCF-7	breast:
11	chr9:136606377..136608314-chr9:136856987..136859928,3	MCF-7	breast:
12	chr9:136606898..136609884-chr9:136619797..136622653,2	MCF-7	breast:
13	chr9:136622701..136625023-chr9:136856638..136859174,2	MCF-7	breast:
14	chr9:136607693..136608878-chr9:136859235..136860612,8	MCF-7	breast:
15	chr9:136600827..136603339-chr9:136606377..136608244,2	K562	blood:
16	chr9:136607827..136608773-chr9:136859602..136860351,4	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DBH-5	chr9:136614146-136614544	NONHSAT135340
2	lnc-DBH-2	chr9:136619187-136619393	XLOC_007595
3	lnc-DBH-2	chr9:136619625-136620083	XLOC_007595
4	lnc-DBH-5	chr9:136614859-136616857	NONHSAT135340
5	lnc-SARDH-2	chr9:136627017-136628425	NONHSAT135342

Variant related genes	Relation type
SARDH	TF binding region
ENSG00000256225	chromatin interactions
ENSG00000160293	chromatin interactions

Extended variants
information (count: 971 )
Associated
traits (count: 90 )

Variant overlapped rSNPs/rCNVs (count:971 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3758345	chr9:136607461-136607462	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs529813922	chr9:136607465-136607466	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs542255907	chr9:136607472-136607473	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs548349477	chr9:136607481-136607482	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs146318614	chr9:136607501-136607502	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs533868685	chr9:136607575-136607576	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs370372392	chr9:136607576-136607577	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs570416556	chr9:136607590-136607591	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs112676963	chr9:136607612-136607613	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs556545394	chr9:136607615-136607616	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs575062047	chr9:136607645-136607646	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs113449979	chr9:136607647-136607648	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs139014115	chr9:136607657-136607658	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs554343937	chr9:136607696-136607697	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs185705516	chr9:136607701-136607702	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs78221635	chr9:136607723-136607724	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs564141279	chr9:136607744-136607745	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs562842579	chr9:136607776-136607777	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs531567977	chr9:136607809-136607810	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs544507436	chr9:136607827-136607828	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs143151991	chr9:136607869-136607870	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs529978692	chr9:136607904-136607905	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs187700993	chr9:136607919-136607920	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs560378482	chr9:136607935-136607936	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs563434110	chr9:136608000-136608001	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs527386634	chr9:136608008-136608009	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs191390651	chr9:136608078-136608079	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs552275045	chr9:136608086-136608087	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs570479080	chr9:136608087-136608088	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs577230259	chr9:136608128-136608129	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs372998334	chr9:136608176-136608177	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs549730424	chr9:136608188-136608189	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs139537059	chr9:136608202-136608203	Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs150849987	chr9:136608226-136608227	Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs138589120	chr9:136608266-136608267	Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs554083436	chr9:136608271-136608272	Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs375610098	chr9:136608272-136608273	Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs149286825	chr9:136608277-136608278	Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs557792406	chr9:136608294-136608295	Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs144623403	chr9:136608299-136608300	Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs543480039	chr9:136608308-136608309	Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs562111050	chr9:136608328-136608329	Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs538240923	chr9:136608383-136608384	Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs73662190	chr9:136608387-136608388	Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs56335638	chr9:136608390-136608391	Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs148473623	chr9:136608404-136608405	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs28662453	chr9:136608405-136608406	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs77248393	chr9:136608411-136608412	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs531519992	chr9:136608441-136608442	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs370516529	chr9:136608443-136608444	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:90)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	17603634	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	18632612	CNVD
Cardiac fibroma	18329553	CNVD
Lung cancer	19147751	CNVD
Melanoma	18172304	CNVD
Cervical cancer	16585170	CNVD
Ependymoma	19289631	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Cervical cancer	17311676	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastric cancer	17908304	CNVD
Breast cancer	16608533	CNVD
Metanephric adenoma	20802469	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Chordoma	18071362	CNVD
small cell lung cancer	20016488	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Kleefstra Syndrome	21538692	CNVD
Disorders of sex development	22290220	CNVD
Cancer	21183584	CNVD
Chronic myelomonocytic leukemia	16760666	CNVD
Abnormal phenotypes	18644119	CNVD
Ovarian cancer	21720365	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Sudden cardiac death	19188705	CNVD
Myoepithelioma	18604193	CNVD
Tuberous sclerosis	19566914	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21364760	CNVD
Cancer	20581869	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Hepatocellular carcinoma	22174799	CNVD
Bladder cancer	21909424	CNVD
Cancer	17160897	CNVD
Ependymoma	20639864	CNVD
Breast cancer	20932292	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
T-cell lymphomas	22341440	CNVD
Pancreatic cancer	17952125	CNVD
Idiopathic chronic pancreatitis	21572526	CNVD
Kleefstra syndrome	22670141	CNVD
Schizophrenia	22241247	CNVD
9q deletion syndrome	16826528	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Non-small cell lung cancer	21829676	CNVD
Non-syndromic sensorineural hearing loss	19293338	CNVD
Neurodevelopmental disorder	22521361	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:286 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:136604000-136608000	Weak transcription	Fetal Lung	lung
2	chr9:136604000-136608000	Weak transcription	Pancreas	Pancrea
3	chr9:136604600-136607600	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
4	chr9:136605400-136610000	Enhancers	Liver	Liver
5	chr9:136606600-136607600	Weak transcription	HepG2	liver
6	chr9:136606600-136610600	Weak transcription	Fetal Intestine Small	intestine
7	chr9:136606800-136608200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr9:136607200-136607800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
9	chr9:136607400-136607600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
10	chr9:136607600-136607800	Enhancers	HepG2	liver
11	chr9:136607800-136608000	Enhancers	Breast Myoepithelial Primary Cells	Breast
12	chr9:136607800-136608000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
13	chr9:136607800-136608000	Bivalent Enhancer	Fetal Muscle Leg	muscle
14	chr9:136607800-136608200	Flanking Active TSS	HepG2	liver
15	chr9:136607800-136608400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
16	chr9:136608000-136608200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr9:136608000-136608200	Enhancers	HUES64 Cell Line	embryonic stem cell
18	chr9:136608000-136608200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
19	chr9:136608000-136608200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
20	chr9:136608000-136608200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
21	chr9:136608000-136608200	Enhancers	Pancreas	Pancrea
22	chr9:136608000-136608400	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
23	chr9:136608000-136608400	Enhancers	Fetal Lung	lung
24	chr9:136608200-136610000	Enhancers	HepG2	liver
25	chr9:136608200-136616400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
26	chr9:136608400-136608600	Bivalent Enhancer	Fetal Lung	lung
27	chr9:136610000-136610400	Weak transcription	Liver	Liver
28	chr9:136610000-136610400	Weak transcription	HepG2	liver
29	chr9:136610400-136611400	Enhancers	Liver	Liver
30	chr9:136610400-136613000	Enhancers	HepG2	liver
31	chr9:136610600-136610800	Enhancers	Fetal Intestine Small	intestine
32	chr9:136610800-136611000	Bivalent Enhancer	Duodenum Mucosa	Duodenum
33	chr9:136612200-136612800	Enhancers	K562	blood
34	chr9:136613000-136614800	Weak transcription	HepG2	liver
35	chr9:136614800-136615400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
36	chr9:136614800-136615400	Enhancers	HepG2	liver
37	chr9:136615400-136616200	Weak transcription	HepG2	liver
38	chr9:136615400-136616600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
39	chr9:136616200-136617000	ZNF genes & repeats	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr9:136616200-136620800	Enhancers	HepG2	liver
41	chr9:136616400-136617000	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr9:136616600-136618600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
43	chr9:136616800-136621000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
44	chr9:136617000-136617200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
45	chr9:136617000-136618000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
46	chr9:136617000-136618200	Enhancers	Fetal Thymus	thymus
47	chr9:136617000-136620600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
48	chr9:136617000-136629000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
49	chr9:136617200-136617600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr9:136617400-136617800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links